脱氮酶
蛋白酵素
生物
泛素
计算生物学
酶
疾病
生物化学
医学
基因
病理
作者
Xin Pan,Sihua Wu,Wenping Wei,Zixuan Chen,Yong Wu,Kaizheng Gong
出处
期刊:Biomolecules
[MDPI AG]
日期:2022-06-29
卷期号:12 (7): 910-910
被引量:10
摘要
Deubiquitinating enzymes (DUBs) are a group of proteases that are important for maintaining cell homeostasis by regulating the balance between ubiquitination and deubiquitination. As the only known metalloproteinase family of DUBs, JAB1/MPN/Mov34 metalloenzymes (JAMMs) are specifically associated with tumorigenesis and immunological and inflammatory diseases at multiple levels. The far smaller numbers and distinct catalytic mechanism of JAMMs render them attractive drug targets. Currently, several JAMM inhibitors have been successfully developed and have shown promising therapeutic efficacy. To gain greater insight into JAMMs, in this review, we focus on several key proteins in this family, including AMSH, AMSH-LP, BRCC36, Rpn11, and CSN5, and emphatically discuss their structural basis, diverse functions, catalytic mechanism, and current reported inhibitors targeting JAMMs. These advances set the stage for the exploitation of JAMMs as a target for the treatment of various diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI